Advanced search
1 file | 94.44 KB

Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis

(2009) PLOS ONE. 4(11).
Author
Organization
Abstract
Standard short course chemotherapy is recommended by the World Health Organization to control tuberculosis worldwide. However, in settings with high drug resistance, first line standard regimens are linked with high treatment failure. We evaluated treatment outcomes after standardized chemotherapy with the WHO recommended category II retreatment regimen in a prison with a high prevalence of drug resistant tuberculosis (TB). A cohort of 233 culture positive TB patients was followed through smear microscopy, culture, drug susceptibility testing and DNA fingerprinting at baseline, after 3 months and at the end of treatment. Overall 172 patients (74%) became culture negative, while 43 (18%) remained positive at the end of treatment. Among those 43 cases, 58% of failures were determined to be due to treatment with an inadequate drug regimen and 42% to either an initial mixed infection or re-infection while under treatment. Overall, drug resistance amplification during treatment occurred in 3.4% of the patient cohort. This study demonstrates that treatment failure is linked to initial drug resistance, that amplification of drug resistance occurs, and that mixed infection and re-infection during standard treatment contribute to treatment failure in confined settings with high prevalence of drug resistance.
Keywords
MIXED INFECTION, MYCOBACTERIUM-TUBERCULOSIS, MDR-TB, OUTBREAK, PATTERNS, STRAINS, GEORGIA, PRISONS, RUSSIA

Downloads

  • http www.ncbi.nlm.nih.gov pmc articles PMC2776350 pdf pone.0007954.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 94.44 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Matthys, Francine, Leen Rigouts, Vinciane Sizaire, Natalia Vezhnina, Maryvonne Lecoq, Vera Golubeva, Françoise Portaels, Patrick Van Der Stuyft, and Michael Kimerling. 2009. “Outcomes After Chemotherapy with WHO Category II Regimen in a Population with High Prevalence of Drug Resistant Tuberculosis.” Plos One 4 (11).
APA
Matthys, Francine, Rigouts, L., Sizaire, V., Vezhnina, N., Lecoq, M., Golubeva, V., Portaels, F., et al. (2009). Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. PLOS ONE, 4(11).
Vancouver
1.
Matthys F, Rigouts L, Sizaire V, Vezhnina N, Lecoq M, Golubeva V, et al. Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. PLOS ONE. 2009;4(11).
MLA
Matthys, Francine et al. “Outcomes After Chemotherapy with WHO Category II Regimen in a Population with High Prevalence of Drug Resistant Tuberculosis.” PLOS ONE 4.11 (2009): n. pag. Print.
@article{935417,
  abstract     = {Standard short course chemotherapy is recommended by the World Health Organization to control tuberculosis worldwide. However, in settings with high drug resistance, first line standard regimens are linked with high treatment failure. We evaluated treatment outcomes after standardized chemotherapy with the WHO recommended category II retreatment regimen in a prison with a high prevalence of drug resistant tuberculosis (TB). A cohort of 233 culture positive TB patients was followed through smear microscopy, culture, drug susceptibility testing and DNA fingerprinting at baseline, after 3 months and at the end of treatment. Overall 172 patients (74%) became culture negative, while 43 (18%) remained positive at the end of treatment. Among those 43 cases, 58% of failures were determined to be due to treatment with an inadequate drug regimen and 42% to either an initial mixed infection or re-infection while under treatment. Overall, drug resistance amplification during treatment occurred in 3.4% of the patient cohort. This study demonstrates that treatment failure is linked to initial drug resistance, that amplification of drug resistance occurs, and that mixed infection and re-infection during standard treatment contribute to treatment failure in confined settings with high prevalence of drug resistance.},
  author       = {Matthys, Francine and Rigouts, Leen and Sizaire, Vinciane and Vezhnina, Natalia and Lecoq, Maryvonne and Golubeva, Vera and Portaels, Françoise and Van Der Stuyft, Patrick and Kimerling, Michael},
  issn         = {1932-6203},
  journal      = {PLOS ONE},
  keywords     = {MIXED INFECTION,MYCOBACTERIUM-TUBERCULOSIS,MDR-TB,OUTBREAK,PATTERNS,STRAINS,GEORGIA,PRISONS,RUSSIA},
  language     = {eng},
  number       = {11},
  title        = {Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis},
  url          = {http://dx.doi.org/10.1371/journal.pone.0007954},
  volume       = {4},
  year         = {2009},
}

Altmetric
View in Altmetric
Web of Science
Times cited: